Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-01-01 @ 8:05 PM
Study NCT ID:
NCT03588650
Status:
COMPLETED
Last Update Posted:
2022-06-03
First Post:
2018-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-22
First Submit QC Date:
None
Study First Post Date:
2018-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-01
Last Update Post Date:
2022-06-03
Last Update Post Date Type:
ACTUAL